The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
An agreement with such a big name. Considering the low level of the SP yesterday (on a 5-year chart) I would have thought that a 90% rise was more appropriate, and to the point. Such a weak market this, on AIM, for responding to good news....
Look at Toronto stock Pulsar since 29.2.24, from 0.55$ to 1.59$, that's 189% up! Maybe good helium news at HE1 ought to be rewarded more, similar to what's happened with plsr. Go here to see plsr's price chart and newsflow: Https://shorturl.at/lCNY6
Tightening uranium market
Https://www.youtube.com/watch?app=desktop&v=BLcqLe55twc
when does neo start to reflect this?
I decided to sell the lot. Got burnt with IOG this Autumn, can't risk that (administration) happening again. Also this Board doesn't seem to have a clue about solving this, or - as many have suggested - want this demise to occur and then reappear in some other guise.
jason saying grow umr to 20, 30 or 40p/share. seems to me that the no. of near-production assets identified in east and south africa (by *****on & jason) are probably too numerous for maru and ska to take, as portfolio projects, and that's why imo they need a third vehicle like umr, with the advantage of a main market listing (not aim).
https://audioboom.com/posts/8416396-midweek-takeaway-with-jason-brewer-executive-director-of-unicorn-mineral-resources-lse-umr
Like many on AIM they did a (very) low-price placing. The plus side is that the funding is secure for a longer period into the future. That gives a sounder base, going forward. So let's revisit that buy territory of above 50p ;-)
Broader field mentioned: Other pre-clinical studies have been conducted that demonstrate that oral gallium maltolate may prove to be a viable treatment alternative across multiple solid tumors as well